Riaan Research Initiative Inc
- Assets
- $1.7m
- Revenue
- $788.1k
- Investments
- $0.0
- Employees
- 0
- Location
- Oakland Gardens, NY
- Founding
- Data as of
- 05/2023
- EIN
- 87-1188456
Organization Overview
Riaan Research Initiative Inc is located in Oakland Gardens, NY. According to its NTEE Classification (G05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Riaan Research Initiative Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 05/2023, Riaan Research Initiative Inc generated $788.1k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 2 years, the organization has seen revenues fall by an average of (27.9%) each year. All expenses for the organization totaled $219.3k during the year ending 05/2023. As we would expect to see with falling revenues, expenses have declined by (23.5%) per year over the past 2 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO CREATE A WORLD WHERE EVERY CHILD WITH A FATAL GENETIC DISEASE HAS A PATHWAY TOWARD TREATMENT. THE ORGANIZATION IS DEDICATED TO PROMOTING AND FURTHERING TRANSLATIONAL SCIENTIFIC RESEARCH TO ADVANCE TREATMENTS FOR SEVERE AND LIFE-TIMING GENETIC DISORDERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH PROJECTS - RIAAN RESEARCH INITIATIVE IS DEDICATED TO ADVANCING, ACCELERATING, AND FUNDING TRANSLATIONAL SCIENTIFIC RESEARCH TO GENERATE TREATMENTS FOR SEVERE AND LETHAL NEURODEGENERATIVE GENETIC DISORDERS THAT IMPACT THE PEDIATRIC POPULATION SUCH AS COCKAYNE SYNDROME. THE ORGANIZATION'S PROGRAMMATIC AREAS INCLUDE SUPPORTING THE DEVELOPMENT OF COCKAYNE SYNDROME GENE REPLACEMENT THERAPY, AND DRUG REPURPOSING SCREENS BY PARTNERING WITH RESEARCHERS AND ACADEMIC INSTITUTIONS AND ISSUING GRANTS. GENE THERAPY WORK INVOLVES ACCELERATING THE DEVELOPMENT OF ADENOVIRUS VECTORS AND SUPPORTING PRE-CLINICAL TO CLINICAL RESEARCH STUDIES; THE ORGANIZATION'S DRUG REPURPOSING PROJECTS INVOLVE SCREENING SMALL MOLECULES TO IDENTIFY DRUGS THAT CAN HALT OR REVERSE NEURODEGENERATION IN THIS PATIENT POPULATION. THE ORGANIZATION ALSO PROVIDES EDUCATION AND RESOURCES TO THE MEDICAL AND RARE DISEASE COMMUNITY, THE MEDIA, AS WELL AS MEMBERS OF THE PUBLIC ON ADVANCEMENTS IN SCIENTIFIC RESEARCH AND GENERAL COCKAYNE SYNDROME AWARENESS AND MAINTAINS A PATIENT REGISTRY TO GATHER RELEVANT CLINICAL DATA FOR FUTURE TRIALS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Gurjot Kaur Founder/chair | OfficerTrustee | 25 | $0 |
Ajit Singh Secretary | OfficerTrustee | 1 | $0 |
Aasees Kaur Treasurer | OfficerTrustee | 10 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $787,156 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $787,156 |
| Total Program Service Revenue | $0 |
| Investment income | $989 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $788,145 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $9,768 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $202,032 |
| Advertising and promotion | $0 |
| Office expenses | $7,195 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $327 |
| All other expenses | $0 |
| Total functional expenses | $219,322 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,719,798 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $1,719,798 |
| Accounts payable and accrued expenses | $10,000 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $10,000 |
| Net assets without donor restrictions | $1,709,798 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,719,798 |
Grants Awarded
Over the last fiscal year, Riaan Research Initiative Inc has awarded $336,631 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
UMASS MEDICAL SCHOOL PURPOSE: RESEARCH PROJECT | $311,631 |
RAREBASE PBC PURPOSE: RESEARCH PROJECT | $25,000 |